NanoRepro AG
Research NanoRepro AG (NN6.DE) on Bullrun: market cap EUR 20.12M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNN6.DE
- ExchangeXETRA
- CountryGermany
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 20.12M
- Financial periodFY2024
- RevenueEUR 4.65M
- Revenue growth43.2%
- Net income-EUR 2.05M
- Free cash flowEUR 9.46M
- Gross margin63.4%
Valuation Snapshot
latest market cap is EUR 20.12M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2024 | EUR 4.65M | -EUR 2.05M | EUR 9.46M | 63.4% | -0.16 | EUR 9.10M | n/a | EUR 38.14M |
| FY2023 | EUR 3.25M | -EUR 4.69M | -EUR 10.26M | 58.3% | -0.37 | EUR 16.60M | n/a | EUR 40.38M |
| FY2022 | EUR 39.00M | -EUR 3.72M | EUR 9.84M | 31.4% | -0.29 | EUR 31.26M | EUR 0 | EUR 47.43M |
| FY2021 | EUR 162.79M | EUR 29.72M | EUR 8.21M | 34.8% | 2.3 | EUR 28.02M | EUR 150.00K | EUR 57.61M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-04 | EUR 20.12M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
| Year | Dividends/share |
|---|---|
| FY2023 | 0.15 EUR |
| FY2022 | 0.5 EUR |
About NanoRepro AG
NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. The company provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. It offers rapid diagnostic tests, such as family planning, and preventive healthcare line products. The company also develops and commercializes immunochromatographic lateral flow tests;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is NanoRepro AG's market cap?
NanoRepro AG's market capitalization is EUR 20.12M.
What does NanoRepro AG do?
NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. The company provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. It offers rapid diagnostic tests, such as family planning, and preventive healthcare line products. The company also develops and commercializes immunochromatographic lateral flow tests; and tests for hospitals and medical practices.